Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1953 1
1955 2
1956 1
1957 7
1958 1
1960 1
1961 11
1962 15
1963 11
1964 19
1965 21
1966 20
1967 18
1968 22
1969 30
1970 23
1971 35
1972 17
1973 37
1974 36
1975 47
1976 57
1977 57
1978 55
1979 47
1980 58
1981 75
1982 88
1983 83
1984 121
1985 103
1986 100
1987 115
1988 113
1989 167
1990 146
1991 127
1992 143
1993 170
1994 165
1995 191
1996 181
1997 223
1998 245
1999 203
2000 218
2001 180
2002 238
2003 244
2004 241
2005 260
2006 263
2007 243
2008 242
2009 267
2010 261
2011 285
2012 285
2013 303
2014 327
2015 294
2016 325
2017 343
2018 348
2019 327
2020 415
2021 464
2022 432
2023 387
2024 407
2025 111

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,240 results

Results by year

Filters applied: . Clear all
Page 1
Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-Analysis.
Valgimigli M, Gragnano F, Branca M, Franzone A, da Costa BR, Baber U, Kimura T, Jang Y, Hahn JY, Zhao Q, Windecker S, Gibson CM, Watanabe H, Kim BK, Song YB, Zhu Y, Vranckx P, Mehta S, Ando K, Hong SJ, Gwon HC, Serruys PW, Dangas GD, McFadden EP, Angiolillo DJ, Heg D, Calabrò P, Jüni P, Mehran R; Single Versus Dual Antiplatelet Therapy (Sidney-3) Collaboration. Valgimigli M, et al. Among authors: watanabe h. JAMA Cardiol. 2024 May 1;9(5):437-448. doi: 10.1001/jamacardio.2024.0133. JAMA Cardiol. 2024. PMID: 38506796
Regulation of lymphoid-myeloid lineage bias through regnase-1/3-mediated control of Nfkbiz.
Uehata T, Yamada S, Ori D, Vandenbon A, Giladi A, Jelinski A, Murakawa Y, Watanabe H, Takeuchi K, Toratani K, Mino T, Kiryu H, Standley DM, Tsujimura T, Ikawa T, Kondoh G, Landthaler M, Kawamoto H, Rodewald HR, Amit I, Yamamoto R, Miyazaki M, Takeuchi O. Uehata T, et al. Among authors: watanabe h. Blood. 2024 Jan 18;143(3):243-257. doi: 10.1182/blood.2023020903. Blood. 2024. PMID: 37922454 Free PMC article.
Takayasu phlebitis.
Katayama Y, Matsumoto Y, Yamamura Y, Asano Y, Hayashi K, Ohashi K, Morishita M, Watanabe H, Narazaki M, Sada KE, Wada J. Katayama Y, et al. Among authors: watanabe h. Rheumatology (Oxford). 2020 Dec 1;59(12):e131-e133. doi: 10.1093/rheumatology/keaa333. Rheumatology (Oxford). 2020. PMID: 32617559 No abstract available.
A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial.
Hosokawa K, Watanabe H, Taniguchi Y, Ikeda N, Inami T, Yasuda S, Murohara T, Hatano M, Tamura Y, Yamashita J, Tatsumi K, Tsujino I, Kobayakawa Y, Adachi S, Yaoita N, Minatsuki S, Todaka K, Fukuda K, Tsutsui H, Abe K; KABUKI Investigators. Hosokawa K, et al. Among authors: watanabe h. Circulation. 2024 Jan 30;149(5):406-409. doi: 10.1161/CIRCULATIONAHA.123.067528. Epub 2023 Nov 13. Circulation. 2024. PMID: 37956127 Free PMC article. Clinical Trial. No abstract available.
Identification of olfactory alarm substances in zebrafish.
Masuda M, Ihara S, Mori N, Koide T, Miyasaka N, Wakisaka N, Yoshikawa K, Watanabe H, Touhara K, Yoshihara Y. Masuda M, et al. Among authors: watanabe h. Curr Biol. 2024 Apr 8;34(7):1377-1389.e7. doi: 10.1016/j.cub.2024.02.003. Epub 2024 Feb 28. Curr Biol. 2024. PMID: 38423017
Inhibitory Roles of Apolipoprotein E Christchurch Astrocytes in Curbing Tau Propagation Using Human Pluripotent Stem Cell-Derived Models.
Murakami R, Watanabe H, Hashimoto H, Kashiwagi-Hakozaki M, Hashimoto T, Karch CM; Dominantly Inherited Alzheimer Network (DIAN),; Iwatsubo T, Okano H. Murakami R, et al. Among authors: watanabe h. J Neurosci. 2024 Jun 12;44(24):e1709232024. doi: 10.1523/JNEUROSCI.1709-23.2024. J Neurosci. 2024. PMID: 38649269 Free PMC article.
An Aspirin-Free Strategy for Immediate Treatment Following Complex Percutaneous Coronary Intervention.
Yamamoto K, Natsuaki M, Watanabe H, Morimoto T, Obayashi Y, Nishikawa R, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Tamura T, Kawahatsu K, Hayashi F, Akao M, Serikawa T, Mori H, Kawamura T, Hagikura A, Shibata N, Ono K, Kimura T; STOPDAPT-3 Investigators. Yamamoto K, et al. Among authors: watanabe h. JACC Cardiovasc Interv. 2024 May 13;17(9):1119-1130. doi: 10.1016/j.jcin.2024.03.017. JACC Cardiovasc Interv. 2024. PMID: 38749592
Aspirin vs. clopidogrel monotherapy after percutaneous coronary intervention: 1-year follow-up of the STOPDAPT-3 trial.
Watanabe H, Natsuaki M, Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R, Kimura T, Ando K, Domei T, Suwa S, Ogita M, Isawa T, Takenaka H, Yamamoto T, Ishikawa T, Hisauchi I, Wakabayashi K, Onishi Y, Hibi K, Kawai K, Yoshida R, Suzuki H, Nakazawa G, Kusuyama T, Morishima I, Ono K, Kimura T. Watanabe H, et al. Eur Heart J. 2024 Dec 16;45(47):5042-5054. doi: 10.1093/eurheartj/ehae617. Eur Heart J. 2024. PMID: 39215959 Clinical Trial.
Association of HLA-A∗11:01, HLA-B∗39:01, and HLA-B∗56:03 with salazosulfapyridine-induced cutaneous adverse drug reactions.
Fukunaga K, Tsukagoshi E, Nakamura R, Matsunaga K, Ozeki T, Watanabe H, Hasegawa A, Hama N, Kurata M, Mizukawa Y, Watanabe Y, Yamaguchi Y, Niihara H, Morita E, Asada H, Abe R, Saito Y, Mushiroda T. Fukunaga K, et al. Among authors: watanabe h. J Allergy Clin Immunol Pract. 2024 May;12(5):1355-1358.e3. doi: 10.1016/j.jaip.2024.02.041. Epub 2024 Apr 11. J Allergy Clin Immunol Pract. 2024. PMID: 38613561 No abstract available.
Differential Effects of HLA-B∗15:11 and HLA-A∗31:01 on Carbamazepine-Induced Cutaneous Adverse Reactions.
Fukunaga K, Tsukagoshi E, Kurata M, Mizukawa Y, Niihara H, Morita E, Watanabe Y, Yamaguchi Y, Watanabe H, Nakajima S, Nomura T, Kabashima K, Tohyama M, Azukizawa H, Asada H, Hasegawa A, Hama N, Ozeki T, Mashimo Y, Sekine A, Matsunaga K, Tanaka Y, Nakamura R, Abe R, Mushiroda T, Saito Y. Fukunaga K, et al. Among authors: watanabe h. J Invest Dermatol. 2024 Apr;144(4):908-911.e7. doi: 10.1016/j.jid.2023.09.282. Epub 2023 Oct 30. J Invest Dermatol. 2024. PMID: 37914023 No abstract available.
10,240 results
You have reached the last available page of results. Please see the User Guide for more information.